Articles

Browse normalized, publication-ready research with direct links to its evidence and source.

Loading articles data…

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Readable research linked to original sources

Articles

Browse normalized, publication-ready research with direct links to its evidence and source.

Filters

Clear all

Article type

Publication year

19172026

From yearTo year

Keyword

Active filter

Author: Priscila A. Costa

1 articles

Newest first

Research Article 2022CC BYCC BY allows this article to remain publicly readable here. Any reuse must still follow the recorded source terms.Free full text

Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses.

Laísa S. Umpierrez, Priscila A. Costa, Eden A. Michelutti, Sarah J. Baracz, Melanie Sauer, Anita J. Turner +4 more

Rationale Cannabidiol (CBD) and cannabidiolic acid (CBDA) are non-psychoactive components of the cannabis plant. CBD has been well characterised to have anxiolytic and anticonvulsant activity, whereas the behavioural effects of CBDA are less clear. Preclinical and clinical data suggests that CBD has antipsychotic properties and reduces methamphetamine self-administration in rats. An animal model that is commonly u…

Psychopharmacology Europe PMC↗

Open article record in new tab ↗

End of results

The service organizes published evidence. It does not provide medical advice.